A viral trend called ‘heightmaxxing’ has reportedly led some teenagers to experiment with erdafitinib, a prescription cancer drug, in the hope of increasing their height. However, interfering with the body’s growth pathways without medical supervision can have serious consequences, particularly during adolescence.
Dr Monika Sharma, Senior Consultant – Endocrinology, Aakash Healthcare, explains that erdafitinib is an anti-cancer medication prescribed for certain types of urothelial cancer, including bladder cancer, in patients with specific genetic alterations in the fibroblast growth factor receptor (FGFR).
“Erdafitinib works by blocking FGFR proteins, which are involved in regulating cell growth, replication and development. The interest in this drug among teenagers appears to stem from the role of FGFR signalling in bone development and growth plates. However, this relationship is complex.…